sygnaturediscovery.com

Evaluation du site sygnaturediscovery.com

Sygnature Discovery - Leading Contract Research Organisation

 Généré le 06 Avril 2026 22:57

Vieilles statistiques? UPDATE !

Le score est de 63/100

Optimisation du contenu

Titre

Sygnature Discovery - Leading Contract Research Organisation

Longueur : 60

Parfait, votre titre contient entre 10 et 70 caractères.

Description

Sygnature Discovery is a world-leading integrated drug discovery CRO based in the UK and Canada with headquarters in Nottingham (UK).

Longueur : 133

Génial, votre balise META description contient entre 70 et 160 caractères.

Mots-clefs

Très mauvais. Nous n'avons pas trouvé de balise META keywords sur votre page. Utilisez ce générateur gratuit de balises META en ligne pour créer des mots-clés.

Propriétés Open Graph

Bien, cette page profite des balises META Open Graph.

Propriété Contenu
locale en_US
type website
title Sygnature Discovery - Leading Contract Research Organisation
description Sygnature Discovery is a world-leading integrated drug discovery CRO based in the UK and Canada with headquarters in Nottingham (UK).
url https://www.sygnaturediscovery.com/
site_name Sygnature
image https://www.sygnaturediscovery.com/wp-content/uploads/2026/02/sygnature-hit-to-lead-team-collaboration-scaled.webp
image:width 2560
image:height 1707
image:type image/webp

Niveaux de titre

H1 H2 H3 H4 H5 H6
1 25 28 137 8 0
  • [H1] Achieving exceptional scientific outcomesthrough connected drug discovery.
  • [H2] World-leading drug discovery solutions, accelerating your compound to the clinic.
  • [H2] We offer deep expertise across the full range of drug discovery solutions.
  • [H2] We deliver world-class scientific expertise and flexible services across every discipline in preclinical discovery.
  • [H2] Integrated Drug Discovery
  • [H2] Computer Aided Drug Design
  • [H2] Protein & Structure
  • [H2] Bioscience
  • [H2] Chemistry
  • [H2] Drug Metabolism and Pharmacokinetics (DMPK)
  • [H2] in vivo Pharmacology
  • [H2] Form and Formulation
  • [H2] We offer specialist expertise across a range of modalities, target classes and therapeutic areas.
  • [H2] Modalities
  • [H2] Target Classes
  • [H2] Therapeutic Areas
  • [H2] World-leading drug discovery
  • [H2] At Sygnature Discovery, we create exceptional scientific outcomes
  • [H2] Reshaping drug discovery by uniting technology, disciplines and talent across Europe and North America
  • [H2] Impact that lasts
  • [H2] Our track record
  • [H2] Trusted by customers worldwide
  • [H2] Interested in joining our team?
  • [H2] News & Resources
  • [H2] Ready to start a conversation?
  • [H2] You're in the right place!
  • [H3] Featured Resources
  • [H3] Featured Resources
  • [H3] Featured Resources
  • [H3] in vivo Pharmacology solutions
  • [H3] Featured Resources
  • [H3] Ion channels Ion channels
  • [H3] Featured Resources
  • [H3] Featured Resources Overview
  • [H3] Featured Resources
  • [H3] Categories View all
  • [H3] Featured Resources
  • [H3] Featured Resources
  • [H3] Featured Resources
  • [H3] Featured Resources
  • [H3] in vivo Pharmacology solutions
  • [H3] Featured Resources
  • [H3] Ion channels Ion channels
  • [H3] Featured Resources
  • [H3] Featured Resources
  • [H3] Categories View all
  • [H3] Featured Resources
  • [H3] From Lead to Pre-Candidate Nomination in 18 Months
  • [H3] Sitryx: Empowering New Ideas
  • [H3] Rapid creation of ideas using generative AI (GenAI) with Iktos Makya
  • [H3] Corcept Therapeutics: Integrated Drug Discovery Collaboration
  • [H3] CellCentric Lead Optimisation Campaign – CCS1477
  • [H3] Fragment-based hit discovery for the epigenetic target, BRD3
  • [H3] Hit Identification to 3 Compounds in the Clinic and 6 Development Candidates
  • [H4] Integrated Drug Discovery
  • [H4] Target Identification & Validation
  • [H4] Hit Identification
  • [H4] Hit-to-Lead
  • [H4] Lead Optimization
  • [H4] STORM Therapeutics: From Lead to Pre-Candidate Nomination in 18 Months
  • [H4] Computer Aided Drug Design
  • [H4] Bioinformatics
  • [H4] Target Analysis
  • [H4] Virtual Screening
  • [H4] Structure Based Drug Design
  • [H4] Generative AI and Machine Learning
  • [H4] Ligand Based Drug Design
  • [H4] Library Design
  • [H4] ADMET Predictions
  • [H4] Informatics
  • [H4] Rapid creation of ideas using generative AI (GenAI) with Iktos Makya
  • [H4] Protein Science and Structural Biology
  • [H4] Protein Expression and Purification
  • [H4] Membrane Proteins
  • [H4] Antibodies and Biotherapeutics
  • [H4] Structural Biology
  • [H4] X-Ray Crystallography
  • [H4] cryo-EM
  • [H4] Macromolecular NMR
  • [H4] Protein Characterization
  • [H4] Protein Mass Spectrometry
  • [H4] FIDA
  • [H4] A Comparison of the Structural Techniques used at Sygnature Discovery: X-ray Crystallography, NMR and Cryo-EM
  • [H4] Bioscience
  • [H4] Cell Line Generation
  • [H4] Assay Development
  • [H4] Electrophysiology
  • [H4] High Throughput Screening
  • [H4] Cell Based Assays
  • [H4] Biochemical Assays
  • [H4] Biophysical Assays
  • [H4] Primary Cells and Tissues
  • [H4] Integrating Hit Finding and Direct-to-Biology to Shorten Time to Development Candidate
  • [H4] Chemistry
  • [H4] Medicinal Chemistry
  • [H4] Synthetic Chemistry
  • [H4] Process & Scale-up Chemistry
  • [H4] NMR-Spectroscopy
  • [H4] Separation Sciences
  • [H4] High Throughput Chemistry
  • [H4] Why Early Process Chemistry Matters?
  • [H4] Drug Metabolism and Pharmacokinetics
  • [H4] Physicochemical Profiling
  • [H4] Chemical & Metabolic Stability
  • [H4] Permeability
  • [H4] Tissue Binding
  • [H4] Drug-Drug Interactions
  • [H4] Biotransformation
  • [H4] Analytical Method Development & Bioanalysis
  • [H4] in vivo Pharmacokinetic & Pharmacodynamic Studies
  • [H4] PK & PK/PD Modelling and Simulation
  • [H4] DMPK Consultancy
  • [H4] Dedicated DMPK for Bifunctional Degraders: A Flexible Approach for Flexible Molecules
  • [H4] in vivo Pharmacology
  • [H4] CNS/Pain Models
  • [H4] Metabolic Disease Models
  • [H4] Inflammation & Immunology Models
  • [H4] Oncology Models
  • [H4] Non-Regulatory Toxicology
  • [H4] in vivo Pharmacokinetics
  • [H4] ex vivo Tissue Analysis
  • [H4] Evaluation of Two Novel Compounds Compared to Methadone on Morphine Withdrawal in a Rat Model of Physical dependence
  • [H4] Form & Formulation
  • [H4] Early Clinical Formulation
  • [H4] Solid Form Analysis
  • [H4] Salt and Co-Crystal Screening
  • [H4] Polymorph Screening
  • [H4] Pre-Clinical Formulation
  • [H4] Assessing Lypoprotectant Effect on Particle Size of Liposomal Systems
  • [H4] Modalities
  • [H4] Small Molecules
  • [H4] Peptides
  • [H4] Targeted protein degradation
  • [H4] ADCs
  • [H4] Biologics
  • [H4] Next-Generation Antibody Drug Conjugates
  • [H4] Ion Channels
  • [H4] GABAA Receptors
  • [H4] NMDA Receptors
  • [H4] Glycine Receptors
  • [H4] Nicotinic Receptors
  • [H4] TRP Channels
  • [H4] Sodium Channels
  • [H4] Calcium Channels
  • [H4] Potassium Channels
  • [H4] Chloride Channels
  • [H4] TMEM175
  • [H4] Delivering Custom Cell-Based Tools for Drug Discovery
  • [H4] Sygnature Discovery Successfully Provides Clinical Candidate to Corcept Therapeutics
  • [H4] Therapeutic Areas
  • [H4] Oncology and Immuno-Oncology
  • [H4] Inflammation and Immunology
  • [H4] Neuroscience
  • [H4] Metabolic Diseases
  • [H4] CellCentric Lead Optimisation Campaign - CCS1477
  • [H4] Blog
  • [H4] Webinars & Podcasts
  • [H4] Posters
  • [H4] Journal Papers
  • [H4] Technical Notes
  • [H4] Case Studies
  • [H4] eBooks
  • [H4] Protocols
  • [H4] News
  • [H4] Events
  • [H4] About Sygnature
  • [H4] Meet our Team
  • [H4] Careers
  • [H4] Integrated Drug Discovery
  • [H4] Target Identification & Validation
  • [H4] Hit Identification
  • [H4] Hit-to-Lead
  • [H4] Lead Optimization
  • [H4] STORM Therapeutics: From Lead to Pre-Candidate Nomination in 18 Months
  • [H4] Modalities
  • [H4] Small Molecules
  • [H4] Peptides
  • [H4] Targeted protein degradation
  • [H4] ADCs
  • [H4] Biologics
  • [H4] Next-Generation Antibody Drug Conjugates
  • [H4] Therapeutic Areas
  • [H4] Oncology and Immuno-Oncology
  • [H4] Inflammation and Immunology
  • [H4] Neuroscience
  • [H4] Metabolic Diseases
  • [H4] CellCentric Lead Optimisation Campaign - CCS1477
  • [H4] About Sygnature
  • [H4] Meet our Team
  • [H4] Careers
  • [H4] UK (Nottingham)
  • [H5] Our Office Locations
  • [H5] Drug Discovery
  • [H5] modalities
  • [H5] Target Classes
  • [H5] Scientific solutions
  • [H5] Therapeutic Areas
  • [H5] Website
  • [H5] Resource Hub

Images

Nous avons trouvé 77 image(s) sur cette page Web.

38 attribut(s) alt sont vides ou manquants. Ajouter un texte alternatif permet aux moteurs de recherche de mieux comprendre le contenu de vos images.

Ratio texte/HTML

Ratio : 26%

Idéal! le ratio de cette page texte/HTML est entre 25 et 70 pour cent.

Flash

Parfait, aucun contenu FLASH n'a été détecté sur cette page.

Iframe

Dommage, vous avez des Iframes sur vos pages Web, cela signifie que son contenu ne peut pas être indexé par les moteurs de recherche.

Réécriture d'URLs

Bien. Vos liens sont optimisés!

Tiret bas dans les URLs

Nous avons détectés des soulignements dans vos URLs. Vous devriez plutôt utiliser des tirets pour optimiser votre référencement.

Liens dans la page

Nous avons trouvé un total de 70 lien(s) dont 4 lien(s) vers des fichiers

Texte d'ancre Type Juice
Explore the STORM Therapeutics case study Interne Passing Juice
Contact Interne Passing Juice
Contact us Interne Passing Juice
Get in touch Interne Passing Juice
What we do Interne Passing Juice
Learn more about Drug Discovery Interne Passing Juice
Learn more about Scientific Solutions Interne Passing Juice
Explore CADD Interne Passing Juice
Explore Protein and Structure Interne Passing Juice
Explore Bioscience Interne Passing Juice
Explore Chemistry Interne Passing Juice
Explore DMPK Interne Passing Juice
Explore in vivo Pharmacology Interne Passing Juice
Explore Form and Formulation Interne Passing Juice
Discover our Modalities Interne Passing Juice
Learn more about Target Classes Interne Passing Juice
Explore our Therapeutic Areas Interne Passing Juice
At Sygnature Discovery, we create exceptional scientific outcomes Interne Passing Juice
Reshaping drug discovery by uniting technology, disciplines and talent across Europe and North America Interne Passing Juice
Impact that lasts Interne Passing Juice
Learn more Interne Passing Juice
Read the case study Interne Passing Juice
Read the case study Interne Passing Juice
Read the case study Interne Passing Juice
Read the case study Interne Passing Juice
Read the case study Interne Passing Juice
Read the case study Interne Passing Juice
View our Careers Page Interne Passing Juice
Bringing Connected Drug Discovery Together Under One Name Interne Passing Juice
Dr Simon Hirst awarded prestigious honorary Doctorate from the University of Nottingham Interne Passing Juice
Sygnature Discovery Completes Major Enhancement of High-Throughput Chemistry Facilities Following £1 Million Investment Interne Passing Juice
Sygnature Discovery boosts growth of its in vivo Pharmacology business with appointment of new Vice President Interne Passing Juice
Sygnature Discovery Appoints New Chief Commercial Officer to Drive Next Phase of Business Growth Interne Passing Juice
Sygnature Discovery appoints Rick Davies to spearhead growth as Director of its UK Protein Sciences and Structural Biology business (formerly, Peak Proteins) Interne Passing Juice
View all locations Interne Passing Juice
Target Identification & Validation Interne Passing Juice
Hit Identification Interne Passing Juice
Hit-to-Lead Interne Passing Juice
Lead Optimization Interne Passing Juice
Small Molecules Interne Passing Juice
Peptides Interne Passing Juice
Targeted Protein Degradation Interne Passing Juice
ADCs Interne Passing Juice
Biologics Interne Passing Juice
Ion channels Interne Passing Juice
GPCRs Interne Passing Juice
Transporters Interne Passing Juice
Oncology Interne Passing Juice
Inflammation and Immunology Interne Passing Juice
Neuroscience Interne Passing Juice
Metabolic Diseases Interne Passing Juice
Meet our Team Interne Passing Juice
Working with us Interne Passing Juice
Environmental, social, governance Interne Passing Juice
Blog Interne Passing Juice
Webinars & Podcasts Interne Passing Juice
Posters Interne Passing Juice
Journal Papers Interne Passing Juice
Technical Notes Interne Passing Juice
eBooks Interne Passing Juice
Protocols Interne Passing Juice
Case Studies Interne Passing Juice
News Interne Passing Juice
Events Interne Passing Juice
Privacy Policy Interne Passing Juice
Cookie Policy Interne Passing Juice
Website terms of use Interne Passing Juice
Modern Slavery Statement Interne Passing Juice
Supplier Code of Conduct Interne Passing Juice
Website Design Agency Externe Passing Juice

Mots-clefs

Nuage de mots-clefs

from design target solutions drug chemistry expertise integrated sygnature discovery

Cohérence des mots-clefs

Mot-clef Contenu Titre Mots-clefs Description Niveaux de titre
discovery 91
drug 68
sygnature 33
integrated 26
expertise 25

Ergonomie

Url

Domaine : sygnaturediscovery.com

Longueur : 22

Favicon

Génial, votre site web dispose d'un favicon.

Imprimabilité

Génial. L'impression est optimisée grâce aux styles CSS.

Langue

Bien. Votre langue est : en.

Dublin Core

Cette page ne profite pas des métadonnées Dublin Core.

Document

Doctype

HTML 5

Encodage

Parfait. Votre charset est UTF-8.

Validité W3C

Erreurs : 0

Avertissements : 0

E-mail confidentialité

Attention! Au moins une adresse e-mail a été trouvée en texte clair. Utilisez une protection anti-spam gratuite pour cacher vos e-mails aux spammeurs.

HTML obsolètes

Génial! Nous n'avons pas trouvé de balises HTML obsolètes dans votre code.

Astuces vitesse

Excellent, votre site n'utilise pas de tableaux imbriqués.
Mauvais, votre site web utilise des styles css inline.
Mauvais, votre site web contient trop de fichiers CSS (plus de 4).
Mauvais, votre site web contient trop de fichiers javascript (plus de 6).
Parfait : votre site tire parti de gzip.

Mobile

Optimisation mobile

Icône Apple
Méta tags viewport
Contenu FLASH

Optimisation

Sitemap XML

Votre site web dispose d’une sitemap XML, ce qui est optimal.

https://www.sygnaturediscovery.com/sitemap_index.xml

Robots.txt

https://sygnaturediscovery.com/robots.txt

Votre site dispose d’un fichier robots.txt, ce qui est optimal.

Mesures d'audience

Manquant

Nous n'avons trouvé aucun outil d'analytics sur ce site.

Un outil de mesure d'audience vous permet d'analyser l’activité des visiteurs sur votre site. Vous devriez installer au moins un outil Analytics. Il est souvent utile d’en rajouter un second, afin de confirmer les résultats du premier.

PageSpeed Insights

Dispositif
Les catégories

Free SEO Testing Tool

Free SEO Testing Tool est un outil gratuit de référencement qui vous aidera à analyser vos pages web